NM_001378454.1:c.69_74dupGGAGGA

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BA1

The NM_001378454.1(ALMS1):​c.69_74dupGGAGGA​(p.Glu24_Glu25dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E25E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.059 ( 291 hom., cov: 0)
Exomes 𝑓: 0.063 ( 154 hom. )

Consequence

ALMS1
NM_001378454.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:12

Conservation

PhyloP100: 0.369

Publications

7 publications found
Variant links:
Genes affected
ALMS1 (HGNC:428): (ALMS1 centrosome and basal body associated protein) This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]
ALMS1 Gene-Disease associations (from GenCC):
  • Alstrom syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001378454.1
BP6
Variant 2-73385903-T-TGGAGGA is Benign according to our data. Variant chr2-73385903-T-TGGAGGA is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 218713.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALMS1NM_001378454.1 linkc.69_74dupGGAGGA p.Glu24_Glu25dup disruptive_inframe_insertion Exon 1 of 23 ENST00000613296.6 NP_001365383.1
ALMS1NM_015120.4 linkc.69_74dupGGAGGA p.Glu24_Glu25dup disruptive_inframe_insertion Exon 1 of 23 NP_055935.4 Q8TCU4
LOC105374804XR_007087045.1 linkn.-228_-223dupTCCTCC upstream_gene_variant
LOC105374804XR_007087053.1 linkn.-228_-223dupTCCTCC upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALMS1ENST00000613296.6 linkc.69_74dupGGAGGA p.Glu24_Glu25dup disruptive_inframe_insertion Exon 1 of 23 1 NM_001378454.1 ENSP00000482968.1 Q8TCU4-1

Frequencies

GnomAD3 genomes
AF:
0.0595
AC:
8536
AN:
143400
Hom.:
292
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0228
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.105
Gnomad ASJ
AF:
0.0698
Gnomad EAS
AF:
0.0755
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.0617
Gnomad MID
AF:
0.0603
Gnomad NFE
AF:
0.0672
Gnomad OTH
AF:
0.0595
GnomAD2 exomes
AF:
0.0668
AC:
5566
AN:
83366
AF XY:
0.0657
show subpopulations
Gnomad AFR exome
AF:
0.0205
Gnomad AMR exome
AF:
0.115
Gnomad ASJ exome
AF:
0.0393
Gnomad EAS exome
AF:
0.0629
Gnomad FIN exome
AF:
0.0320
Gnomad NFE exome
AF:
0.0484
Gnomad OTH exome
AF:
0.0477
GnomAD4 exome
AF:
0.0632
AC:
35210
AN:
557130
Hom.:
154
Cov.:
0
AF XY:
0.0645
AC XY:
19197
AN XY:
297462
show subpopulations
African (AFR)
AF:
0.0218
AC:
345
AN:
15792
American (AMR)
AF:
0.106
AC:
3314
AN:
31164
Ashkenazi Jewish (ASJ)
AF:
0.0554
AC:
977
AN:
17620
East Asian (EAS)
AF:
0.0749
AC:
2295
AN:
30636
South Asian (SAS)
AF:
0.0967
AC:
5400
AN:
55846
European-Finnish (FIN)
AF:
0.0494
AC:
1792
AN:
36292
Middle Eastern (MID)
AF:
0.0665
AC:
161
AN:
2422
European-Non Finnish (NFE)
AF:
0.0566
AC:
19101
AN:
337270
Other (OTH)
AF:
0.0607
AC:
1825
AN:
30088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.409
Heterozygous variant carriers
0
1727
3454
5181
6908
8635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0594
AC:
8530
AN:
143504
Hom.:
291
Cov.:
0
AF XY:
0.0622
AC XY:
4327
AN XY:
69588
show subpopulations
African (AFR)
AF:
0.0227
AC:
908
AN:
39946
American (AMR)
AF:
0.105
AC:
1537
AN:
14686
Ashkenazi Jewish (ASJ)
AF:
0.0698
AC:
232
AN:
3322
East Asian (EAS)
AF:
0.0753
AC:
345
AN:
4580
South Asian (SAS)
AF:
0.112
AC:
475
AN:
4256
European-Finnish (FIN)
AF:
0.0617
AC:
579
AN:
9386
Middle Eastern (MID)
AF:
0.0602
AC:
16
AN:
266
European-Non Finnish (NFE)
AF:
0.0672
AC:
4322
AN:
64268
Other (OTH)
AF:
0.0589
AC:
116
AN:
1968
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
327
654
982
1309
1636
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0447
Hom.:
1022

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:12
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Alstrom syndrome Uncertain:5Benign:2
Nov 12, 2015
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:7
Jun 23, 2015
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 03, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 19, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 07, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Nov 19, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.37
Mutation Taster
=78/22
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55889738; hg19: chr2-73613031; COSMIC: COSV105092294; COSMIC: COSV105092294; API